數位呼吸設備市場－全球產業規模、佔有率、趨勢、機會和預測：按產品、適應症、分銷管道、地區和競爭格局分類，2021-2031年

全球數位呼吸設備市場預計將經歷顯著成長，從 2025 年的 449.8 億美元成長到 2031 年的 810.9 億美元，複合年成長率達到 10.32%。

該市場涵蓋智慧吸入器、霧化器和肺計量計，這些產品整合了感測器和通訊功能，用於監測患者的用藥依從性和肺功能。主要促進因素包括慢性呼吸系統疾病盛行率的上升以及對遠端患者監護以實現及時醫療干預的需求日益成長。到2025年，世衛組織歐洲區域將有8,170萬人受到慢性呼吸道疾病的影響，凸顯了對先進管理工具的迫切需求。然而，開發和部署這些互聯技術的高昂成本以及有限的保險報銷等重大挑戰正在阻礙市場擴張。這些設備對許多患者來說可能過於昂貴，這可能會限制其在醫療預算有限的地區的普及。這種經濟障礙仍然是全球推廣應用的主要阻礙。

市場促進因素

全球氣喘和慢性阻塞性肺病（COPD）盛行率的上升是推動數位呼吸設備市場發展的主要動力，也因此催生了對智慧吸入器等先進疾病管理工具的強勁需求，以預防症狀加重。日益惡化的環境狀況進一步加劇了這種需求。例如，在美國，有1.31億人生活在空氣污染嚴重、呼吸系統風險增加的環境中。同時，遠端患者監護（RPM）和遠端醫療解決方案的興起，透過物聯網連接實現即時資料傳輸，並允許在無需頻繁就醫的情況下進行個人化治療調整，從而改變了醫療保健的提供方式。這種變革促進了預防性干預，提高了患者的用藥依從性和臨床療效。互聯設備的普及（例如ResMed在全球部署的超過2600萬台設備）為基於價值的醫療保健奠定了堅實的基礎，使數位呼吸設備成為現代醫學不可或缺的一部分。

市場挑戰

市場擴張的一大障礙是研發和購買互聯呼吸技術所需的巨額資金。製造商面臨研發和工程成本飆升的困境，這推高了智慧吸入器和監測設備的零售價格。此外，許多地區缺乏全面的保險報銷機制，迫使患者自費承擔費用，這使得醫療系統難以證明優先採用這些先進解決方案而非更便宜的傳統替代方案的合理性，尤其是在經濟低度開發地區。這種經濟壁壘直接限制了數位化解決方案的普及和市場滲透，進一步加劇了呼吸系統疾病患者本已沉重的經濟負擔。例如，到2025年，氣喘患者的年度醫療費用將比非氣喘患者高出3,266美元，而未獲補貼的數位化設備的額外成本將高得令人難以承受，從而阻礙全球市場成長。

市場趨勢

製藥公司與醫療技術公司之間的策略合作正在從根本上重塑市場格局，轉向將藥物與數位連接相結合的共同開發模式。這些夥伴關係使製藥公司能夠利用感測器技術增強藥物依從性追蹤，同時設備製造商也能獲得更廣泛的患者網路和分銷管道。這種協同增效的方式展現了互聯生態系的商業性可行性。例如，Adherium 等公司交付了4,666 台連網型設備，超過了 2025 年的出貨目標，凸顯了市場對整合監測解決方案日益成長的需求。同時，環保和永續設備設計的開發也獲得了顯著進展。這一趨勢的驅動力來自監管機構日益成長的呼吸護理脫碳壓力，促使人們設計出使用低全球暖化潛勢推進劑和可重複使用組件的吸入器。各公司正積極投資綠色創新，以符合全球環境、社會和治理 (ESG) 要求。例如，Chiesi Farmaceutici 開發了一種“低碳吸入器”，與傳統設備相比，其推進劑氣體排放可減少高達 90%。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球數位呼吸設備市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 產品類別（智慧型吸入器/霧化器、感測器/應用程式、其他）
  • 適應症（氣喘、慢性阻塞性肺病、其他）
  • 銷售管道細分（醫院藥局、零售藥局、網路藥局）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美數位呼吸設備市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲數位呼吸設備市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區數位呼吸設備市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲數位呼吸設備市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲數位呼吸設備市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章 全球數位呼吸設備市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• COHERO Health Inc.
• Cognita Labs llc
• Adherium Limited
• Amiko Digital Health Limited
• Teva Pharmaceuticals Industries Ltd.
• Propeller Health
• Novartis AG
• Pneuma Respiratory Inc.
• 3M Health Care Limited
• AireHealth, Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Digital Respiratory Devices Market is set for substantial growth, projected to increase from USD 44.98 Billion in 2025 to USD 81.09 Billion by 2031, achieving a 10.32% CAGR. This market includes smart inhalers, nebulizers, and spirometers that integrate sensors and connectivity to monitor medication adherence and lung physiology. Key drivers include the rising prevalence of chronic respiratory conditions and the growing demand for remote patient monitoring, which facilitates timely medical interventions. In 2025, chronic respiratory diseases affected 81.7 million people in the WHO European Region, highlighting the critical need for advanced management tools. However, significant challenges like the high cost of developing and acquiring these connected technologies, coupled with limited reimbursement frameworks, could hinder market expansion, making these devices unaffordable for many and restricting their adoption in regions with limited healthcare funding. This financial barrier remains a major obstacle to widespread global implementation.

Market Driver

The increasing global incidence of asthma and COPD is a primary driver for the Digital Respiratory Devices Market, creating a strong demand for advanced disease management tools like smart inhalers to prevent exacerbations. This demand is further amplified by worsening environmental conditions; for instance, 131 million people in the U.S. live with unhealthy air pollution levels, increasing respiratory risks. Concurrently, the rise of remote patient monitoring (RPM) and telehealth solutions is transforming care delivery by enabling real-time data transmission via IoT connectivity, allowing personalized treatment adjustments without frequent hospital visits. This shift facilitates proactive interventions, improving patient adherence and clinical outcomes. The widespread adoption of connected devices, with over 26 million deployed globally by ResMed, underscores the established infrastructure for value-based care, making digital respiratory devices integral to modern medicine.

Market Challenge

A major impediment to market expansion is the substantial capital required for the development and procurement of connected respiratory technologies. Manufacturers face high research and engineering costs, which translate into elevated retail prices for smart inhalers and monitoring devices. Furthermore, the lack of comprehensive reimbursement policies in many regions forces patients to pay out-of-pocket, making these advanced solutions difficult for healthcare systems, especially in economically constrained areas, to justify over less expensive traditional alternatives. This economic barrier directly limits the uptake and market penetration of digital solutions, exacerbating the already high financial strain on patients with respiratory conditions. For example, asthma patients incurred annual medical expenses $3,266 higher than individuals without the condition in 2025, making the additional cost of unsubsidized digital devices prohibitive and stalling global market growth.

Market Trends

Strategic collaborations between pharmaceutical companies and medical technology firms are fundamentally reshaping the market by moving towards co-development models that bundle medication with digital connectivity. These partnerships allow pharmaceutical companies to utilize sensor technologies for enhanced adherence tracking, while device manufacturers gain access to broader patient networks and distribution channels. This synergistic approach validates the commercial viability of connected ecosystems, as evidenced by companies like Adherium, which surpassed its 2025 shipment milestones by delivering 4,666 connected devices, confirming rising demand for integrated monitoring solutions. Simultaneously, the development of eco-friendly and sustainable device designs is gaining significant momentum. This trend is driven by increasing regulatory pressure to decarbonize respiratory care, leading to the engineering of inhalers with low-global-warming-potential propellants and reusable components. Corporations are actively investing in green innovation to align with global ESG mandates, with Chiesi Farmaceutici, for example, developing a Carbon Minimal Inhaler designed to reduce propellant gas emissions by up to 90% compared to traditional devices.

Key Market Players

• COHERO Health Inc.
• Cognita Labs llc
• Adherium Limited
• Amiko Digital Health Limited
• Teva Pharmaceuticals Industries Ltd.
• Propeller Health
• Novartis AG
• Pneuma Respiratory Inc.
• 3M Health Care Limited
• AireHealth, Inc.

Report Scope

In this report, the Global Digital Respiratory Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Digital Respiratory Devices Market, By Product

• Smart Inhalers & Nebulizers
• Sensors & Apps
• Others

Digital Respiratory Devices Market, By Indication

• Asthma
• COPD
• Others

Digital Respiratory Devices Market, By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Digital Respiratory Devices Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Digital Respiratory Devices Market.

Available Customizations:

Global Digital Respiratory Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Digital Respiratory Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Smart Inhalers & Nebulizers, Sensors & Apps, Others)
  • 5.2.2. By Indication (Asthma, COPD, Others)
  • 5.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Digital Respiratory Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Indication
  • 6.2.3. By Distribution Channel
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Digital Respiratory Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Indication
      • 6.3.1.2.3. By Distribution Channel
  • 6.3.2. Canada Digital Respiratory Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Indication
      • 6.3.2.2.3. By Distribution Channel
  • 6.3.3. Mexico Digital Respiratory Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Indication
      • 6.3.3.2.3. By Distribution Channel

7. Europe Digital Respiratory Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Indication
  • 7.2.3. By Distribution Channel
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Digital Respiratory Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Indication
      • 7.3.1.2.3. By Distribution Channel
  • 7.3.2. France Digital Respiratory Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Indication
      • 7.3.2.2.3. By Distribution Channel
  • 7.3.3. United Kingdom Digital Respiratory Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Indication
      • 7.3.3.2.3. By Distribution Channel
  • 7.3.4. Italy Digital Respiratory Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Indication
      • 7.3.4.2.3. By Distribution Channel
  • 7.3.5. Spain Digital Respiratory Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Indication
      • 7.3.5.2.3. By Distribution Channel

8. Asia Pacific Digital Respiratory Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Indication
  • 8.2.3. By Distribution Channel
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Digital Respiratory Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Indication
      • 8.3.1.2.3. By Distribution Channel
  • 8.3.2. India Digital Respiratory Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Indication
      • 8.3.2.2.3. By Distribution Channel
  • 8.3.3. Japan Digital Respiratory Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Indication
      • 8.3.3.2.3. By Distribution Channel
  • 8.3.4. South Korea Digital Respiratory Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Indication
      • 8.3.4.2.3. By Distribution Channel
  • 8.3.5. Australia Digital Respiratory Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Indication
      • 8.3.5.2.3. By Distribution Channel

9. Middle East & Africa Digital Respiratory Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Indication
  • 9.2.3. By Distribution Channel
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Digital Respiratory Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Indication
      • 9.3.1.2.3. By Distribution Channel
  • 9.3.2. UAE Digital Respiratory Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Indication
      • 9.3.2.2.3. By Distribution Channel
  • 9.3.3. South Africa Digital Respiratory Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Indication
      • 9.3.3.2.3. By Distribution Channel

10. South America Digital Respiratory Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Indication
  • 10.2.3. By Distribution Channel
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Digital Respiratory Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Indication
      • 10.3.1.2.3. By Distribution Channel
  • 10.3.2. Colombia Digital Respiratory Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Indication
      • 10.3.2.2.3. By Distribution Channel
  • 10.3.3. Argentina Digital Respiratory Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Indication
      • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Digital Respiratory Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. COHERO Health Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Cognita Labs llc
• 15.3. Adherium Limited
• 15.4. Amiko Digital Health Limited
• 15.5. Teva Pharmaceuticals Industries Ltd.
• 15.6. Propeller Health
• 15.7. Novartis AG
• 15.8. Pneuma Respiratory Inc.
• 15.9. 3M Health Care Limited
• 15.10. AireHealth, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer